Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs NEULAND LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES NEULAND LABS DIVIS LABORATORIES/
NEULAND LABS
 
P/E (TTM) x 66.0 25.4 259.5% View Chart
P/BV x 7.1 8.1 88.2% View Chart
Dividend Yield % 0.9 0.2 548.3%  

Financials

 DIVIS LABORATORIES   NEULAND LABS
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-23
NEULAND LABS
Mar-23
DIVIS LABORATORIES/
NEULAND LABS
5-Yr Chart
Click to enlarge
High Rs4,6412,004 231.6%   
Low Rs2,730966 282.7%   
Sales per share (Unadj.) Rs292.6928.4 31.5%  
Earnings per share (Unadj.) Rs68.7127.4 53.9%  
Cash flow per share (Unadj.) Rs81.6168.6 48.4%  
Dividends per share (Unadj.) Rs30.0010.00 300.0%  
Avg Dividend yield %0.80.7 120.9%  
Book value per share (Unadj.) Rs480.9774.8 62.1%  
Shares outstanding (eoy) m265.4712.83 2,069.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x12.61.6 787.5%   
Avg P/E ratio x53.711.7 460.5%  
P/CF ratio (eoy) x45.28.8 512.7%  
Price / Book Value ratio x7.71.9 399.9%  
Dividend payout %43.77.8 556.7%   
Avg Mkt Cap Rs m978,37819,052 5,135.4%   
No. of employees `000NANA-   
Total wages/salary Rs m9,7502,018 483.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m77,67511,912 652.1%  
Other income Rs m3,44797 3,535.7%   
Total revenues Rs m81,12212,009 675.5%   
Gross profit Rs m23,6912,718 871.5%  
Depreciation Rs m3,432528 650.2%   
Interest Rs m20131 15.0%   
Profit before tax Rs m23,6862,157 1,097.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,453522 1,044.0%   
Profit after tax Rs m18,2341,635 1,115.1%  
Gross profit margin %30.522.8 133.7%  
Effective tax rate %23.024.2 95.1%   
Net profit margin %23.513.7 171.0%  
BALANCE SHEET DATA
Current assets Rs m97,4377,609 1,280.6%   
Current liabilities Rs m15,3314,390 349.3%   
Net working cap to sales %105.727.0 391.1%  
Current ratio x6.41.7 366.7%  
Inventory Days Days86 131.7%  
Debtors Days Days8421,109 76.0%  
Net fixed assets Rs m51,1288,189 624.4%   
Share capital Rs m531129 411.5%   
"Free" reserves Rs m127,1409,812 1,295.8%   
Net worth Rs m127,6719,941 1,284.3%   
Long term debt Rs m0742 0.0%   
Total assets Rs m148,56515,798 940.4%  
Interest coverage x1,209.517.5 6,907.1%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.50.8 69.3%   
Return on assets %12.311.2 109.9%  
Return on equity %14.316.4 86.8%  
Return on capital %18.621.4 86.7%  
Exports to sales %85.773.5 116.6%   
Imports to sales %19.815.1 130.7%   
Exports (fob) Rs m66,5378,750 760.4%   
Imports (cif) Rs m15,3781,804 852.4%   
Fx inflow Rs m66,5378,750 760.4%   
Fx outflow Rs m15,7151,804 871.1%   
Net fx Rs m50,8226,946 731.7%   
CASH FLOW
From Operations Rs m24,5972,372 1,036.9%  
From Investments Rs m-27,076-615 4,402.7%  
From Financial Activity Rs m-7,972-1,358 587.0%  
Net Cashflow Rs m-10,451403 -2,591.6%  

Share Holding

Indian Promoters % 51.9 32.8 158.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.7 29.1 126.2%  
FIIs % 14.9 22.7 65.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 67.2 71.5%  
Shareholders   354,482 27,723 1,278.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Divis Laboratories vs NEULAND LABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs NEULAND LABS Share Price Performance

Period Divis Laboratories NEULAND LABS S&P BSE HEALTHCARE
1-Day 2.14% -1.12% 1.18%
1-Month -2.15% -11.56% -0.75%
1-Year 22.51% 269.91% 61.82%
3-Year CAGR -1.38% 43.81% 18.16%
5-Year CAGR 15.77% 59.26% 19.79%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the NEULAND LABS share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of NEULAND LABS the stake stands at 32.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of NEULAND LABS.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 43.7%.

NEULAND LABS paid Rs 10.0, and its dividend payout ratio stood at 7.8%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of NEULAND LABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.